Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Identify a reliable starting point by focusing on liquidity, security, and real-world use cases that resonate with new investors.
23,507 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
April 2026 data show a 2.4% year-over-year drop in new-home purchase applications, the first annual decline since lat...
Midweek is a prime time to refresh your investment plan. This Wednesday Reads guide breaks down tax-smart moves, mark...
As market rates swing and volatility persists, a 4.75% yield from an active covered-call ETF is reshaping retirement ...
AMZY, the YieldMax AMZN Option Income Strategy ETF, uses a synthetic covered-call approach to generate monthly distri...
SpaceX unveiled a century long strategy spanning launches, Starlink, and AI, pushing the company toward a potential $...
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
Tesla's robotaxi venture is facing real-world hurdles in Texas. This article breaks down what those problems mean for...
Trump’s Iran ceasefire plan draws fierce GOP skepticism, while financial markets react with oil and equities whipsaws...
Star Wars Weekend drew $82 million in opening U.S. box office and is on track to exceed $100 million domestically, bu...
A broad rally in semiconductor stocks persists into late May 2026, driven by AI infrastructure demand. Yet history ca...
Billionaire Tom Steyer has shattered spending records with a $195 million political ad blitz this year, dwarfing riva...